Not Medicare Enrolled

Dr. Thomas Grote, MD

Medical Oncology · N Wilkesboro, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1913 W PARK DR, N Wilkesboro, NC 28659
3369036362
In practice since 2006 (20 years)
NPI: 1215907993 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Grote from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Grote? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Grote

Dr. Thomas Grote is a medical oncology specialist in N Wilkesboro, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Grote performed 673 Medicare services across 416 unique beneficiaries.

Between the years covered by Open Payments, Dr. Grote received a total of $3,318 from 32 pharmaceutical and/or device companies across 195 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Grote is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 34% volume in NC $3,318 industry payments

Medicare Practice Summary

Medicare Utilization ↗
673
Medicare services
Top 34% in NC for medical oncology
416
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~34 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
336 $64 $291
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
210 $104 $425
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
49 $85 $484
New patient office visit, complex (60-74 min) 35 $127 $614
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
25 $8 $22
Telephone medical discussion, 21-30 minutes
A phone conversation with a nonphysician healthcare professional lasting between 21 and 30 minutes.
18 $26 $93
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2022 ↗
$3,318
Total received (2018-2022)
Avg $664/year across 5 years
Bottom 49% in NC for medical oncology
32
Companies
195
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,293 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$102
2021
$314
2020
$16
2019
$128
2018
$2,758

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Sobi, Inc
$102
Top 3 companies account for 100.0% of 2022 payments
All-time payments by company (2018-2022) ›
Novartis Pharmaceuticals Corporation
$456
Janssen Biotech, Inc.
$319
E.R. Squibb & Sons, L.L.C.
$225
Genentech USA, Inc.
$220
AstraZeneca Pharmaceuticals LP
$206
GENZYME CORPORATION
$198
PFIZER INC.
$182
Amgen Inc.
$133
Merck Sharp & Dohme Corporation
$106
Celgene Corporation
$106
Boehringer Ingelheim Pharmaceuticals, Inc.
$105
Sobi, Inc
$102
Kite Pharma, Inc.
$101
Foundation Medicine, Inc.
$86
Exelixis Inc.
$81
Bayer HealthCare Pharmaceuticals Inc.
$75
Lilly USA, LLC
$65
Ipsen Biopharmaceuticals, Inc
$60
Takeda Pharmaceuticals U.S.A., Inc.
$59
Agios Pharmaceuticals, Inc.
$56
Gilead Sciences, Inc.
$55
Eisai Inc.
$44
Seattle Genetics, Inc.
$43
TESARO, Inc.
$40
Astellas Pharma US Inc
$38
Incyte Corporation
$33
Janssen Pharmaceuticals, Inc
$30
EMD Serono, Inc.
$26
Daiichi Sankyo Inc.
$23
Pharmacyclics LLC, An AbbVie Company
$18
Spectrum Pharmaceuticals Inc.
$16
AbbVie, Inc.
$13
Top 3 companies account for 30.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BOSULIF · BRAFTOVI · Bavencio · CABOMETYX · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ELIQUIS · ELITEK · EMPLICITI · Enhertu · FOUNDATIONONE · Folotyn · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Halaven · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LYNPARZA · Lenvima · MYLOTARG · NINLARO · Neulasta · OPDIVO · Perjeta · RYDAPT · Revlimid · SARCLISA · SUTENT · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · VENCLEXTA · VOTRIENT · Vectibix · Venclexta · XALKORI · XARELTO · XTANDI · Xofigo · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a medical oncology specialist in N Wilkesboro?
Compare medical oncologists in the N Wilkesboro area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
1
Per 100K population
1.5
County median income
$50,438
Nearest hospital
WILKES REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Grote is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Grote experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Grote performed 336 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Grote receive payments from pharmaceutical companies?
Yes. Dr. Grote received a total of $3,318 from 32 companies across 195 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Grote's costs compare to other medical oncologists in N Wilkesboro?
Dr. Grote's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Grote) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →